恒辉安防公告称，公司于2025年12月12日召开董事会，审议通过以债转股方式向全资子公司恒越安防增 资1亿元的议案，增资金额全部计入资本公积。本次增资后，恒越安防注册资本仍为3亿元，公司仍持股 100%。该事项尚需股东会审议。恒越安防2024年营收1.09亿元，净利润-1504.47万元；2025年1-9月营收 2.01亿元，净利润335.40万元。此次增资将优化其资产负债结构，符合公司整体战略。 ...

美利信：拟定增募资不超12亿元 12月5日，美利信(301307)发布公告称，公司拟募资不超12亿元（含），用于半导体装备精密结构件建设项目、通信及汽车零部件可钎焊压铸产业化项目以 及补充流动资金。 欧林生物：补缴企业所得税税款420.01万元 12月5日，欧林生物(688319)发布公告称，公司近期配合主管税务机关的工作对公司涉税事项进行了自查。经自查，公司预补缴企业所得税税款共计420.01万 元。目前公司已完成缴纳，主管税务机关未对该事项给予处罚。相关事项尚在沟通与处理过程中，最终金额需税务机关进一步认定。 海森药业：董事及高管拟合计减持不超过12.43万股公司股份 12月5日，海森药业(001367)发布公告称，董事代亚、副总经理张胜权、楼岩军、财务总监潘爱娟、董事会秘书胡康康计划合计减持公司股份不超12.43万 股，占公司总股本的0.0816%。 艾布鲁：拟向实控人等出售控股子公司金鹊农业股权 12月5日，艾布鲁(301259)发布公告称，公司拟将持有的控股子公司金鹊农业47.4%股权转让给钟儒波，将金鹊农业31.6%股权转让给游建军，转让价款合计 1239.14万元。交易完成后，公司将不再持有金鹊 ...

（一）股东会的届次：2025年第三次临时股东会 （四）会议召开的日期、时间 登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：002297 证券简称：博云新材 编号：2025-044 湖南博云新材料股份有限公司 关于召开2025年第三次临时股东会的通知 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚假记载、误导性陈述或者重大 遗漏。 湖南博云新材料股份有限公司（以下简称"公司"或"博云新材"）于2025年12月4日召开第七届董事会第 二十二次会议审议通过了《湖南博云新材料股份有限公司关于提请召开2025年第三次临时股东会的议 案》，现就召开2025年第三次临时股东会（以下简称"本次股东会"）有关事宜通知如下： 一、召开会议的基本情况 现场会议召开时间为：2025年12月22日下午14:30 网络投票时间为：2025年12月22日 其中，通过深圳证券交易所交易系统进行网络投票的具体时间为：2025年12月22日上午9:15至9:25， 9:30至11:30，下午13:00至15:00；通过深圳证券交易所互联网投票系统投票的具体时间为：2025年12月 22日9:15一15:00期间的 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：300859 证券简称：西域旅游 公告编号：2025-055 西域旅游开发股份有限公司 第七届董事会第十一次会议决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记载、误导性陈述或重大遗 漏。 一、董事会会议召开情况 西域旅游开发股份有限公司（以下简称"公司"或"西域旅游"）第七届董事会第十一次会议于2025年12月 1日以现场+通讯表决方式召开，会议通知于2025年11月26日以电话、邮件等方式送达各位董事。本次 会议应出席董事9人，实际出席董事9人，会议由公司董事长吕美蓉女士召集并主持，公司高级管理人员 列席了本次会议。本次会议的召集、召开、表决程序符合《中华人民共和国公司法》《西域旅游开发股 份有限公司章程》和《西域旅游开发股份有限公司董事会议事规则》的有关规定，会议合法有效。 二、董事会会议审议情况 经与会董事认真讨论，审议通过如下议案： 1、审议通过《关于以债转股方式对控股子公司增资的议案》 经与会董事审议，为优化控股子公司新疆准东经济技术开发区古海温泉有限责任公司（以下简称"古海 温泉公司"）资产负债结构，提高资 ...

智通财经APP讯，聚赛龙(301131.SZ)公告，公司董事会审议通过了《关于以债转股方式对全资子公司增 资的议案》，同意公司以债权转股权方式对全资子公司芜湖聚赛龙新材料科技有限公司(简称"芜湖聚赛 龙")增资人民币1.7亿元。本次以债权转股权方式对全资子公司增资事项是公司基于经营管理需要，合 理优化其内部资源配置及资产负债结构。 ...

Core Points - The company, Zhongchu Development Co., Ltd., has announced the first extraordinary general meeting of shareholders for 2025, scheduled for November 14, 2025 [2][15] - The meeting will utilize a combination of on-site and online voting methods, with the online voting system provided by the Shanghai Stock Exchange [2][3] Meeting Details - The meeting will be convened by the board of directors [2] - The record date for shareholders to be eligible to vote is November 11, 2025 [2] - The on-site meeting will take place at 10:30 AM at the Dingxing Building, Beijing [2] Voting Procedures - Online voting will be available through the Shanghai Stock Exchange's voting system, with specific time slots for voting on November 14, 2025 [3] - The voting time through the trading system is from 9:15 AM to 9:25 AM, 9:30 AM to 11:30 AM, and 1:00 PM to 3:00 PM [3] - Internet voting will be available from 9:15 AM to 3:00 PM on the same day [3] Agenda Items - Non-cumulative voting items include proposals to cancel the supervisory board and amend the company's articles of association [6] - Other proposals include amendments to the rules of procedure for shareholder meetings and board meetings, and a capital increase through debt-to-equity swap for a related company [7] - Cumulative voting items include the election of non-independent and independent directors [7] Attendance - All shareholders registered by the end of trading on November 11, 2025, are eligible to attend [9] - Authorized representatives of eligible shareholders can also attend [10] Registration Method - Individual shareholders must present identification and stock account information for registration [12] - Corporate shareholders must provide legal representative identification and company documents for registration [12][14] - Registration can also be done via email or mail [13]

Core Points - The company has ensured that the content of the disclosures is true, accurate, and complete, with no false records or misleading statements [1][11][34] Financial Data - The third-quarter financial report has not been audited [3][10] - The company does not require retrospective adjustments or restatements of previous accounting data [3] - There are no non-recurring profit and loss items applicable [3][4] Shareholder Information - The total number of shareholders with more than 5% shares and the top ten shareholders' holdings have not changed [4] - The company has completed the registration of changes for its subsidiary, increasing its registered capital from 60 million to 90 million RMB [8] Stock Incentive Plan - As of April 28, 2025, 77 individuals can unlock 1.265271 million shares from the first grant of the stock incentive plan, representing 0.70% of the total share capital [4][6] - As of May 23, 2025, 83 individuals can unlock 254129 shares from the reserved grant, representing 0.14% of the total share capital [5] - The company has repurchased and canceled a total of 1.174470 million shares from the stock incentive plan, reducing the total shares from 182,043,105 to 180,868,635 [7] Board and Supervisory Meetings - The company held its 11th board meeting on October 30, 2025, where the third-quarter report was approved unanimously [12][13] - The board approved the adjustment of independent director allowances, increasing from 60,000 to 120,000 RMB per year, effective January 1, 2026 [16] - The board also approved the reappointment of Tianjian Accounting Firm for the 2025 annual audit [20][38] Upcoming Shareholder Meeting - The company will hold its first extraordinary general meeting on November 17, 2025, to discuss various proposals [56][60]

Core Viewpoint - The company aims to optimize its management structure and subsidiary asset-liability balance to enhance profitability through strategic acquisitions and capital restructuring [1] Group 1: Acquisition and Capital Increase - The company plans to acquire 100% equity of Huizhou Junton New Materials Co., Ltd. from its wholly-owned subsidiary Changzhou Huawai New Materials Co., Ltd. for an assessed price of 55.2262 million yuan [1] - Following the acquisition, the company will directly hold 100% equity of Huizhou Junton, transitioning it from a wholly-owned subsidiary to a fully-owned subsidiary [1] - The company will also increase its capital in Huizhou Junton by 80 million yuan through a debt-to-equity swap [1] Group 2: Financial Restructuring of Subsidiaries - To optimize the asset-liability structure of its wholly-owned subsidiary Hangzhou Daoming Kechuang New Materials Co., Ltd., the company will increase its capital by 200 million yuan through a debt-to-equity swap [1]

Core Viewpoint - The company plans to increase capital for its wholly-owned subsidiary, Huangshi Honghe Electronic Materials Technology Co., Ltd., through a debt-to-equity swap amounting to 300 million RMB, raising the subsidiary's registered capital from 700 million RMB to 1 billion RMB [2][3][6]. Group 1: Capital Increase Overview - The capital increase will be executed via a debt-to-equity swap, where the company will convert its 300 million RMB debt owed by Huangshi Honghe into equity [6]. - The registered capital of Huangshi Honghe will increase from 700 million RMB to 1 billion RMB following the capital increase [3][6]. - The board of directors approved the capital increase on September 19, 2025, and it does not require shareholder approval as it does not constitute a related party transaction or a major asset restructuring [4][11]. Group 2: Subsidiary Information - Huangshi Honghe is a wholly-owned subsidiary of the company, with a registered capital of 700 million RMB and located in Hubei Province [5]. - The subsidiary's business scope includes manufacturing and sales of fiberglass and synthetic materials, as well as import and export activities [5]. Group 3: Impact of Capital Increase - The capital increase is expected to enhance the business development of Huangshi Honghe and strengthen the overall capabilities of the company [7]. - The capital increase will not adversely affect the company's normal operations or its consolidated financial statements, as it does not constitute a major asset restructuring [7].

Core Viewpoint - The company announced a capital increase for its wholly-owned subsidiary, Cangzhou Aodexi Chemical Co., Ltd., through a debt-to-equity swap, aimed at improving the subsidiary's capital structure [1][5]. Summary by Sections Capital Increase Overview - The company’s subsidiary, Beijing Aodexi Chemical Co., Ltd., will convert its debt of 130 million yuan into equity, increasing its investment in Cangzhou Aodexi to 150 million yuan, which will represent 100% of Cangzhou Aodexi's registered capital [1][5]. Basic Information of the Capital Increase Target - Cangzhou Aodexi Chemical Co., Ltd. is a limited liability company established on December 9, 2015, with a registered capital of 20 million yuan. The company is located in Cangzhou Lingang Development Zone and is wholly owned by Beijing Aodexi [3]. Financial Status - As of the latest audited figures, Cangzhou Aodexi has total assets of 160.45 million yuan and total liabilities of 194.47 million yuan, resulting in a net asset deficit of 34.03 million yuan. The company reported an operating income of 78.38 million yuan and a net loss of 23.75 million yuan [4][5]. Impact of the Capital Increase - The capital increase is expected to improve Cangzhou Aodexi's asset-liability structure, promoting sustainable operations and aligning with the company's overall development strategy. The subsidiary will remain a wholly-owned subsidiary post-increase, with no adverse effects on the company's financial and operational status [5].